Overview

Preop Dexmedetomidine Attenuates Haemodynamic Responses to Hydrodissection

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Percutaneous tunnelling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant haemodynamic responses such as increases in blood pressure and heart rate. The investigators evaluated whether a single preoperative dexmedetomidine injection attenuated the haemodynamic responses to hydrodissection by reducing the half-maximal effective concentration (EC50) of remifentanil needed to maintain haemodynamic stability during hydrodissection.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Dexmedetomidine
Propofol
Remifentanil